CheckMyRecalls

Zydus Pharmaceuticals (USA) Inc recalls

17 recall notices naming Zydus Pharmaceuticals (USA) Inc since January 2025, in United States. The most recent was published 21 Oct 2026.

Latest recalls (17)

  1. Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for InjectionFDAFailed Impurities/Degradation Specifications.
  2. Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release TabletsFDACGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
  3. Zydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsFDACGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
  4. Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl CapsulesFDAFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
  5. Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesFDASubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
  6. Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
  7. Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate CapsulesFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate…
  8. Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochlorideFDACGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…
  9. Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
  10. Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed Impurity/Degradation Specifications
  11. Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride InjectionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
  12. Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsFDACGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
  13. Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
  14. Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral SuspensionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during…
  15. Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine TabletsFDAPresence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
  16. Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride TabletsFDACGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
  17. Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFDAFailed Impurities/Degradation Specifications